You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR DURLAZA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DURLAZA

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02370680 ↗	Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease	Completed	New Haven Pharmaceuticals, Inc.	Phase 1	2015-02-01	This study is being conducted to evaluate the safety and the length of effect on platelet build-up in the arteries of Durlaza™ as compared to immediate-release Bayer® aspirin 81 mg or subject's current aspirin 81 mg of choice in patients who have Type 2 diabetes mellitus and cardiovascular disease or multiple risk factors of developing cardiovascular disease.
NCT03079999 ↗	Study of Aspirin in Patients With Vestibular Schwannoma	Recruiting	Massachusetts General Hospital	Phase 2	2018-06-11	This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.
NCT03079999 ↗	Study of Aspirin in Patients With Vestibular Schwannoma	Recruiting	United States Department of Defense	Phase 2	2018-06-11	This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DURLAZA

Condition Name

Chart
Table

Condition Name for DURLAZA
Intervention	Trials
Vestibular Schwannoma	1
Acoustic Neuroma	1
Cardiovascular Disease	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DURLAZA
Intervention	Trials
Neuroma, Acoustic	1
Neuroma	1
Neurofibromatosis 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DURLAZA

Trials by Country

Map
Table

Trials by Country for DURLAZA
Location	Trials
United States	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DURLAZA
Location	Trials
Utah	1
Minnesota	1
Massachusetts	1
Iowa	1
Florida	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DURLAZA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DURLAZA
Clinical Trial Phase	Trials
Phase 2	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DURLAZA
Clinical Trial Phase	Trials
Completed	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DURLAZA

Sponsor Name

Chart
Table

Sponsor Name for DURLAZA
Sponsor	Trials
Massachusetts General Hospital	1
United States Department of Defense	1
Massachusetts Eye and Ear Infirmary	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DURLAZA
Sponsor	Trials
Other	2
U.S. Fed	1
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.